{"id":2610,"date":"2026-09-23T12:18:52","date_gmt":"2026-09-23T12:18:52","guid":{"rendered":"https:\/\/nhdbio.com\/?p=2610"},"modified":"2026-09-23T12:18:52","modified_gmt":"2026-09-23T12:18:52","slug":"efectos-de-matriz-en-la-cromatografia-de-liquidos-acoplada-a-espectrometria-de-masas-lc-ms-de-peptidos-seleccion-de-peptidos-sustitutivos","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/","title":{"rendered":"Efectos de matriz en LC\u2013MS: por qu\u00e9 un p\u00e9ptido subrogado puede cuantificar mejor que otro"},"content":{"rendered":"

An intense peptide signal in neat solvent can fade in plasma without a loss of peptide mass. Coeluting matrix components can change electrospray response. A calibrator prepared only in neat solution may therefore misrepresent the response in a biological sample. The practical decision is to test candidate surrogate peptides in the intended matrix and select a quantifier on validated behavior, rather than signal alone.<\/p>\n

A measured example from rituximab analysis<\/h2>\n

In a study comparing LC\u2013MS\/HRMS and LC\u2013MS\/MS methods for rituximab in human plasma, investigators generated surrogate peptides after protein preparation and digestion. Their Table 7 reports matrix effects for several candidate peptides. For the HRMS method, six plasma sources<\/strong> were spiked at 50 \u00b5g\/mL rituximab<\/strong>. Ion suppression differed markedly: FSGS averaged \u221267% (range \u221254% to \u221278%), pQVQ averaged \u221211% (reported range +15% to \u221235%), and pQIVL averaged \u221293% (range \u221288% to \u221295%). The authors used pQIVL only as a qualifier because its matrix effect was large in both MS methods. [1, \u00a72.3.3, Table 7]<\/p>\n\n\n\n\n\n\n\n
HRMS surrogate peptide<\/th>\nMean reported matrix effect<\/th>\nTested setting<\/th>\n<\/tr>\n<\/thead>\n
FSGS<\/td>\n\u221267%<\/td>\nSix human plasma sources; rituximab spike 50 \u00b5g\/mL<\/td>\n<\/tr>\n
pQVQ<\/td>\n\u221211%<\/td>\nSame study and HRMS setting<\/td>\n<\/tr>\n
pQIVL<\/td>\n\u221293%<\/td>\nSame study and HRMS setting; used as qualifier<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

The LC\u2013MS\/MS arm used four plasma sources<\/strong>, spiked at 15 and 300 \u00b5g\/mL<\/strong>. Its Table 7 reports \u221217% mean suppression for pQVQ and \u221222% for pQIVL. Do not merge those numbers with the HRMS values into one generic \u201cpeptide matrix effect\u201d: the instruments, source counts and spike levels differ. [1]<\/p>\n

A practical evaluation design<\/h2>\n

Choose more than one candidate peptide where the protein sequence permits. Confirm each candidate’s identity and separation, then compare response in neat solution, post-extraction matrix and fully processed matrix. The contrast between neat and post-extraction response helps identify ionization effects; the contrast between post-extraction and processed response can reveal preparation loss. Check multiple independent matrix lots and the concentration range that the assay must measure. Track the internal-standard-normalized matrix factor if a suitable isotope-labeled standard is available. The paper used full-length labeled rituximab as an internal standard, which can follow more preparation steps than a peptide added only after digestion. The timing of standard addition must match what the assay claims to correct.<\/p>\n

Treat matrix effects as analyte- and method-specific<\/strong>. A less suppressed peptide still needs acceptable selectivity, calibration, precision and digestion behavior. A highly suppressed candidate can sometimes serve as a qualifier if it remains reliable for identity confirmation, as in the reported pQIVL example; that does not make it a sound sole quantifier. In the same paper, the authors reported calibration and precision results for their two validated methods, but these do not prove transferability to another antibody or instrument. [1, \u00a7\u00a72.3.2\u20132.3.3]<\/p>\n

Decision record for a surrogate peptide<\/h3>\n

For each candidate, record: (a) sequence uniqueness and fragment-ion support, (b) digestion yield and missed-cleavage forms, (c) matrix-factor distribution across independent matrix lots at low and high concentrations, (d) retention-time separation from interference, and (e) performance after internal-standard normalization. Keep rejected candidates and the reason for rejection. An apparent high neat-solvent response cannot substitute for these checks.<\/p>\n

The ICH M10 guideline<\/a> independently defines matrix effect as changed analyte response due to matrix components. For regulatory bioanalytical validation it calls for low and high QC replicates across at least six<\/strong> matrix sources\/lots, with justified flexibility for rare matrices. That is a relevant design benchmark, not an automatic requirement for every exploratory research assay; the paper’s HRMS experiment also used six plasmas, while its MS\/MS arm used four. [2, \u00a7\u00a71.3 and 3.2.3]<\/p>\n

Boundary and next step<\/h2>\n

The measured values come from rituximab surrogate peptides in human plasma<\/strong>, not free peptide standards or NHD products. They show why a sequence’s analytical response cannot be assumed from another sequence. For interpretation of a specific peptide’s exact mass and fragmentation, use the LC\u2013MS identity guide<\/a>; for questions about the meaning of chromatographic area and content, see the purity-versus-assay guide<\/a>. Neither page replaces matrix-matched validation.<\/p>\n

Primary source and claim trail<\/h2>\n
    \n
  1. Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS\/HRMS and LC-MS\/MS) for the Quantification of Rituximab in Human Plasma<\/em><\/a>. Molecules<\/em>. 2021;26:1383. DOI 10.3390\/molecules26051383<\/a>, PMID 33806585. Locations:<\/strong> \u00a72.3.3 and Table 7 (plasma source counts, spike levels, peptide-specific matrix effects and pQIVL qualifier decision); \u00a72.3.2 (calibration context); Methods (full-length stable-isotope rituximab). Table values were checked in the primary full-text XML.<\/li>\n
  2. International Council for Harmonisation. ICH M10: Bioanalytical Method Validation and Study Sample Analysis<\/em><\/a>, final guideline, 2022. Locations:<\/strong> \u00a7\u00a71.3 and 3.2.3; regulatory scope and independent matrix-lot design. This is authoritative method guidance, not evidence of the study’s measured suppression values.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    An intense peptide signal in neat solvent can fade in plasma without a loss of peptide mass. Coeluting matrix components can change electrospray response. A calibrator prepared only in neat solution may therefore misrepresent the response in a biological sample. The practical decision is to test candidate surrogate peptides in the intended matrix and select […]<\/p>\n","protected":false},"author":1,"featured_media":2609,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"","pim_article_type":"","pim_evidence_level":"","pim_reviewer":"Codex AI-assisted editorial review","pim_reviewed_date":"2026-09-23T20:13:54+08:00","pim_editorial_note":"","pim_review_status":"reviewed","pim_review_reason":"English source and numeric audit, independent seven-language and 135 numeric-exception AI reviews, 70\/70 authenticated localized previews with 2,607\/2,607 body nodes visible, generated-image provenance and visual review, internal-link and private-draft dedup checks completed. Author is existing NHD Technical Team WP user #1. Prepublication SEO fields and expected slug checked; verify public canonical, hreflang, schema, robots and sitemap immediately after this post publishes, and conditionally roll back on failure. Backup is listed in All-in-One WP Migration; full restore was not rehearsed. No human or native-language review was performed. V9 PIM source normalization audit: one trailing ASCII space was removed from 2 source title in the live draft metadata; both source rows remain complete and semantically identical to the reviewed manifest. Manifest PIM SHA e6b77c93859248d809df460101374af8633f2b5964e5082a92dd2c96f076b990; live PIM SHA 85a4048a70ced4278f673a69bdf8c015196ded50d794a163cef0a3bb6d4cfc37. This is an AI-assisted review, not a claim of human review.","pim_creation_method":"AI-assisted editorial draft; independent Codex source, image and seven-language review; human professional review not claimed","pim_sources":"[{\"title\":\"Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS\/HRMS and LC-MS\/MS) for the Quantification of Rituximab in Human Plasma\",\"url\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7961417\/\",\"note\":\"Source 1. \u00a72.3.3 and Table 7 (plasma source counts, spike levels, peptide-specific matrix effects and pQIVL qualifier decision); \u00a72.3.2 (calibration context); Methods (full-length stable-isotope rituximab). Table values were check\"},{\"title\":\"International Council for Harmonisation. ICH M10: Bioanalytical Method Validation and Study Sample Analysis, final guideline, 2022. Locations: \u00a7\u00a71.3 and 3.2.3; regulatory scope and independent matrix-lot design. This is\",\"url\":\"https:\/\/database.ich.org\/sites\/default\/files\/M10_Guideline_Step4_2022_0524.pdf\",\"note\":\"Source 2. \u00a7\u00a71.3 and 3.2.3; regulatory scope and independent matrix-lot design. This is authoritative method guidance, not evidence of the study's measured suppression values.\"}]","footnotes":""},"categories":[1],"tags":[],"class_list":["post-2610","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"\nLC\u2013MS Matrix Effects: Choosing a Surrogate Peptide by Evidence<\/title>\n<meta name=\"description\" content=\"In a rituximab plasma method, three surrogate peptides showed different ion suppression. See how to test matrix effects before selecting a quantifier.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/efectos-de-matriz-en-la-cromatografia-de-liquidos-acoplada-a-espectrometria-de-masas-lc-ms-de-peptidos-seleccion-de-peptidos-sustitutivos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LC\u2013MS Matrix Effects: Why One Surrogate Peptide May Quantify Better Than Another\" \/>\n<meta property=\"og:description\" content=\"In a rituximab plasma method, three surrogate peptides showed different ion suppression. See how to test matrix effects before selecting a quantifier.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/efectos-de-matriz-en-la-cromatografia-de-liquidos-acoplada-a-espectrometria-de-masas-lc-ms-de-peptidos-seleccion-de-peptidos-sustitutivos\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-23T12:18:52+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-4.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1774\" \/>\n\t<meta property=\"og:image:height\" content=\"887\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"LC\u2013MS Matrix Effects: Why One Surrogate Peptide May Quantify Better Than Another\",\"datePublished\":\"2026-09-23T12:18:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/\"},\"wordCount\":751,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/featured-4.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/\",\"name\":\"LC\u2013MS Matrix Effects: Choosing a Surrogate Peptide by Evidence\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/featured-4.png\",\"datePublished\":\"2026-09-23T12:18:52+00:00\",\"description\":\"In a rituximab plasma method, three surrogate peptides showed different ion suppression. See how to test matrix effects before selecting a quantifier.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/featured-4.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/featured-4.png\",\"width\":1774,\"height\":887,\"caption\":\"Conceptual illustration of a peptide sample and matrix components entering LC\u2013MS analysis. Not experimental data.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-matrix-effects-surrogate-peptide-selection\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LC\u2013MS Matrix Effects: Why One Surrogate Peptide May Quantify Better Than Another\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/es\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Efectos de matriz en LC\u2013MS: por qu\u00e9 un p\u00e9ptido subrogado puede cuantificar mejor que otro","description":"En un m\u00e9todo plasm\u00e1tico de rituximab, tres p\u00e9ptidos sustitutos mostraron distinta supresi\u00f3n i\u00f3nica; eval\u00fae la matriz antes de cuantificar.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/efectos-de-matriz-en-la-cromatografia-de-liquidos-acoplada-a-espectrometria-de-masas-lc-ms-de-peptidos-seleccion-de-peptidos-sustitutivos\/","og_locale":"es_ES","og_type":"article","og_title":"LC\u2013MS Matrix Effects: Why One Surrogate Peptide May Quantify Better Than Another","og_description":"In a rituximab plasma method, three surrogate peptides showed different ion suppression. See how to test matrix effects before selecting a quantifier.","og_url":"https:\/\/nhdbio.com\/es\/efectos-de-matriz-en-la-cromatografia-de-liquidos-acoplada-a-espectrometria-de-masas-lc-ms-de-peptidos-seleccion-de-peptidos-sustitutivos\/","og_site_name":"NHD","article_published_time":"2026-09-23T12:18:52+00:00","og_image":[{"width":1774,"height":887,"url":"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-4.png","type":"image\/png"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"LC\u2013MS Matrix Effects: Why One Surrogate Peptide May Quantify Better Than Another","datePublished":"2026-09-23T12:18:52+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/"},"wordCount":751,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-4.png","articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/","url":"https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/","name":"Efectos de matriz en LC\u2013MS: por qu\u00e9 un p\u00e9ptido subrogado puede cuantificar mejor que otro","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-4.png","datePublished":"2026-09-23T12:18:52+00:00","description":"En un m\u00e9todo plasm\u00e1tico de rituximab, tres p\u00e9ptidos sustitutos mostraron distinta supresi\u00f3n i\u00f3nica; eval\u00fae la matriz antes de cuantificar.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-4.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-4.png","width":1774,"height":887,"caption":"Conceptual illustration of a peptide sample and matrix components entering LC\u2013MS analysis. Not experimental data."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/peptide-lcms-matrix-effects-surrogate-peptide-selection\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"LC\u2013MS Matrix Effects: Why One Surrogate Peptide May Quantify Better Than Another"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipo t\u00e9cnico de NHD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"El equipo t\u00e9cnico de NHD mantiene documentaci\u00f3n del cat\u00e1logo de uso de investigaci\u00f3n y res\u00famenes de evidencia. Los art\u00edculos revisados \u200b\u200benlazan con art\u00edculos revisados \u200b\u200bpor pares, registros de ensayos y registros regulatorios, conservan hallazgos nulos y limitaciones de estudios, y distinguen las intervenciones publicadas de los materiales del cat\u00e1logo. Se puede utilizar dibujo asistido por AI para la estructura; los enlaces de fuentes y los l\u00edmites de las pruebas permanecen visibles. Este trabajo no es una revisi\u00f3n por pares independiente ni un consejo m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/es\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/2610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/comments?post=2610"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/2610\/revisions"}],"predecessor-version":[{"id":2642,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/2610\/revisions\/2642"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/2609"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=2610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/categories?post=2610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/tags?post=2610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}